Skip to main content

Swetha Srinivasan

Graduate Research Assistant

Swetha Srinivasan

(919) 756-1876
301 Pharmacy Lane, 2316 Kerr Hall, CB# 7573, Chapel Hill, NC, 27599

Swetha’s dissertation work examines real-world racial disparities, treatment initiation, and survival outcomes associated with the receipt of biomarker testing for patients with advanced non-small cell lung cancer. More broadly, she is interested in access, quality, and value of pharmaceutical innovation, with a particular interest in emerging technologies in oncology.

  1. Passero L, Srinivasan S, Roberts MC. Examining the role of language competency in genetic testing awareness among adults in the United States. J Genet Couns. 2022 Apr 6. doi: 10.1002/jgc4.1576. Epub ahead of print. PMID: 35388538.
  2. Actkins KV, Srinivasan S, Spees LP, Turbitt E, Allen CG, Roberts MC. Uptake of Genetic Testing Among Patients with Cancer At Risk for Lynch Syndrome in the National Health Interview Survey. Cancer Prev Res (Phila). 2021;14(10):927-932. doi:10.1158/1940-6207.CAPR-21-0073
  3. Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC. Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet. 2020;28(12):1631-1644. doi:10.1038/s41431-020-00725-5 (Editor’s Choice)
  4. Srinivasan S, Hampel H, Leeman J, Patel A, Rahm AK, Reuland DS, Roberts MC. Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study. Cancer Prev Res (Phila). 2020;13(12):1037-1046. doi:10.1158/1940-6207.CAPR-20-0141